PRESS RELEASE published on 08/07/2025 at 17:45, 10 months 13 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Median Technologies discloses total voting rights and shares as of July 31, 2025, per French regulations. The company pioneers AI-driven medical software for cancer diagnosis and treatment Voting Rights Shares Median Technologies Cancer Diagnosis AI-driven Software
BRIEF published on 07/11/2025 at 18:51, 11 months 9 days ago Median Technologies Secures €37.5 Million Financing with EIB Financing Facility European Investment Bank Median Technologies Cancer Diagnosis Eyonis® LCS
PRESS RELEASE published on 07/11/2025 at 18:46, 11 months 9 days ago Inside Information / Other news releases Median Technologies signs €37.5M financing facility with EIB to support eyonis® AI-powered Software as a Medical Device for cancer diagnosis. Financial independence strengthened for US and EU commercialization Financial Agreement Median Technologies Cancer Diagnosis EIB Financing Eyonis AI
BRIEF published on 07/09/2025 at 17:50, 11 months 11 days ago Median Technologies Reports Mid-Year Liquidity Contract Status Liquidity Contract Transactions Shares Median Technologies Financial Account
PRESS RELEASE published on 07/09/2025 at 17:45, 11 months 11 days ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Median Technologies reports half-year liquidity contract details with TP ICAP. 60,808 shares and €58,893.66 cash as of June 30, 2025. 469 buy and 395 sell transactions in the first half of 2025 Liquidity Contract Transactions Shares TP ICAP Median Technologies
BRIEF published on 05/16/2025 at 17:50, 1 year 1 month ago Median Technologies Announces Voting Rights and Share Capital Details Share Capital Voting Rights Treasury Shares AMF Regulations Median Technologies
PRESS RELEASE published on 05/16/2025 at 17:45, 1 year 1 month ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Median Technologies discloses total voting rights and shares as of April 30, 2025, in compliance with regulations. The French company utilizes AI for cancer diagnosis and treatment Voting Rights Shares AI Median Technologies Cancer Diagnosis
BRIEF published on 03/14/2025 at 17:50, 1 year 3 months ago Median Technologies Maintains its Eligibility for the PEA-PME Scheme PEA-PME Euronext Growth Tax Benefits Eligibility Median Technologies
BRIEF published on 02/24/2025 at 17:50, 1 year 3 months ago Median Technologies: Presentation of eyonis™ LCS at ECR 2025 Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS ECR 2025
BRIEF published on 01/31/2025 at 08:05, 1 year 4 months ago Median Technologies unveils its 2024 financial results and its 2025 outlook Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
Published on 06/20/2026 at 01:00, 1 day 5 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 6 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 2 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 5 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 5 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 9 hours 20 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 10 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 1 day 11 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 11 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 11 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days 12 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days 13 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days 13 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026